Tension-Type Headache: A Comprehensive Clinical Guide

Pain Spa | Dr M. Krishna | Specialist Interventional Pain Management

What Are Tension-Type Headaches?

Tension-type headache (TTH) is the most common primary headache disorder worldwide. Its core clinical characteristics can be summarised as follows:

• Bilateral headache (affecting both sides of the head)
• Pressing or tightening (non-pulsating) quality
• Mild to moderate intensity
• Duration ranging from 30 minutes to 7 days
• Not aggravated by routine physical activity
• Absence of nausea or vomiting
• Presence of either photophobia or phonophobia, but not both

Clinically, patients often describe the pain as a “band-like” or pressure sensation around the head, frequently associated with neck stiffness or a feeling of muscular tightness. While often perceived as a benign condition, the cumulative burden of recurrent or chronic tension-type headache can be substantial, particularly when it becomes frequent or persistent.

Epidemiology and Clinical Impact

Tension-type headache affects more than half of the adult population, with lifetime prevalence estimates ranging from 30% to 78%. It is the most prevalent neurological disorder globally and ranks among the most common conditions across all disease categories according to the Global Burden of Disease data.

The prevalence typically peaks in the fourth decade of life and is slightly more common in men than women. Although individual episodes are often less disabling than migraine, the overall burden is significant due to frequency. Approximately 8% of patients with episodic tension-type headache report missing work, while those with chronic forms may lose an average of 27 workdays per year.

The socioeconomic impact is therefore considerable, not only due to lost productivity but also due to the cumulative effect of persistent discomfort, reduced quality of life, and frequent healthcare utilisation.

Classification of Tension-Type Headache

Tension-type headache is classified based on attack frequency, which has important implications for management and prognosis.

Infrequent episodic tension-type headache occurs on fewer than 1 day per month (less than 12 days per year).

Frequent episodic tension-type headache occurs on 1 to 14 days per month for more than 3 months (12 to 179 days per year).

Chronic tension-type headache occurs on 15 or more days per month for more than 3 months (180 or more days per year).

Chronic tension-type headache has a prevalence of approximately 2–3% and is frequently associated with medication overuse, anxiety, depression, and central pain amplification mechanisms.

This classification is not merely descriptive; it reflects a shift in underlying pathophysiology and guides treatment decisions, particularly the need for preventive strategies.

Diagnostic Criteria (ICHD-3)

The diagnosis of tension-type headache is based on the International Classification of Headache Disorders (ICHD-3) criteria and requires at least 10 episodes fulfilling the following:

Duration: 30 minutes to 7 days

At least two of the following characteristics:

• Bilateral location
• Pressing or tightening (non-pulsating) quality
• Mild to moderate intensity
• Not aggravated by routine physical activity

Both of the following:

• No nausea or vomiting
• No more than one of photophobia or phonophobia

Exclusion: The headache is not better explained by another diagnosis.

In clinical practice, diagnosis is based on careful history-taking and pattern recognition, as there are no specific biomarkers or imaging findings that confirm tension-type headache. It is therefore essential to consider the overall clinical context and exclude secondary causes where appropriate.

Clinical Features and Examination Findings

Patients with tension-type headache typically present with a dull, pressure-like pain affecting both sides of the head. The discomfort is often described as a tight band or sensation of heaviness rather than a throbbing or pulsating pain. Unlike migraine, the headache is not aggravated by routine physical activity, and most patients are able to continue with their daily tasks.

One of the most consistent and clinically relevant examination findings is pericranial muscle tenderness, particularly involving the temporalis, trapezius, and suboccipital regions. This tenderness tends to increase with headache frequency and intensity and is considered one of the most important physical markers supporting the diagnosis of tension-type headache.

Patients may also report associated features such as neck stiffness, a feeling of muscular tightness, or discomfort radiating from the neck to the head. These features often reflect underlying myofascial involvement and may contribute to symptom persistence.

Neurological examination is otherwise normal. The presence of focal neurological deficits, altered consciousness, or other abnormal findings should prompt consideration of secondary causes and further investigation.

Why Is It Called a “Tension” Headache?

The name “tension headache” reflects a deliberate compromise by the International Headache Society to acknowledge that some form of “tension” — either muscular or psychological — may contribute to the condition, while also recognising that the exact underlying mechanism is not fully explained by either factor alone.

Historical Terminology

Before headache classification was standardised, this condition was described using several different names, each reflecting a different theory about its cause. These included muscle contraction headache, psychomyogenic headache, stress headache, psychogenic headache, ordinary headache, essential headache and idiopathic headache.

The term “tension-type headache” was introduced to replace these older labels. The addition of “type” is important because it avoids suggesting that muscular tension or psychological stress alone is the proven cause. Instead, it reflects the multifactorial nature of the disorder.

The Dual Meaning of “Tension”

The word “tension” has two clinically relevant meanings in this context.

Muscular tension refers to the peripheral component of tension-type headache. Patients may have harder, more tender pericranial muscles and more frequent myofascial trigger points than people without headache. Increased pericranial tenderness on manual palpation is one of the most important abnormal physical findings and is used clinically to support the diagnosis.

Mental or psychological tension refers to the central and emotional component. Stress, anxiety and emotional strain can reduce the effectiveness of the body’s natural pain-inhibiting systems while also increasing muscle tension through limbic and autonomic pathways. This can amplify nociceptive input from the head, neck and shoulder muscles.

Modern Interpretation

Modern understanding no longer views tension-type headache as purely muscular or purely psychological. In episodic tension-type headache, peripheral myofascial mechanisms are often dominant. In chronic tension-type headache, central sensitisation becomes increasingly important, with prolonged nociceptive input leading to amplified pain processing within the nervous system.

This is why the term “tension-type headache” remains useful: it acknowledges the historical role of muscular and psychological tension, while allowing for a more modern neurobiological explanation involving both peripheral pain generators and central pain amplification.

Distinguishing Tension-Type Headache from Migraine

Distinguishing tension-type headache from migraine and secondary headache disorders relies primarily on clinical history and pattern recognition, as no diagnostic biomarkers exist for primary headache disorders. The diagnosis is based on recognised clinical criteria and careful evaluation of symptom patterns.

Key Clinical Differences

Clinical Decision Tools (Validated Tools)

Two validated clinical tools are widely used in primary care to help identify migraine and improve diagnostic accuracy:

• POUND mnemonic: Pulsating quality, 4–72 hOurs duration, Unilateral location, Nausea, Disabling intensity. Headaches with four or more of these features are most likely migraine.
• ID Migraine rule: A three-item screening tool assessing light sensitivity, nausea or vomiting, and activity-limiting headache. Positive responses increase the likelihood of migraine.

These validated tools are particularly useful in patients with overlapping features, where distinguishing between migraine and tension-type headache can be challenging.

Diagnostic Pitfalls

The most common diagnostic challenge is distinguishing tension-type headache from mild migraine without aura. Many patients experience both conditions, and symptom patterns may overlap.

When a headache fulfils criteria for both probable migraine and definite tension-type headache, the definite diagnosis of tension-type headache takes precedence. Careful history-taking and recognition of symptom patterns remain essential to avoid misclassification and inappropriate treatment.

Red Flags and When to Investigate

While tension-type headache is a primary headache disorder, it is essential to exclude secondary causes when red flags are present. Careful clinical assessment remains the most important step in identifying patients who require further investigation.

The SNNOOP10 framework provides a structured and clinically useful approach to identifying concerning features that may indicate an underlying secondary headache disorder.

Key Red Flags (SNNOOP10 Framework)

Emergency vs Non-Emergency Red Flags

Emergency features requiring immediate assessment include:

• Thunderclap headache (sudden severe onset)
• Fever with neck stiffness (possible meningitis)
• Papilloedema with neurological deficits
• Altered consciousness
• Acute visual disturbance with eye pain (possible acute glaucoma)

Non-emergency but concerning features include:

• New headache in patients over 50 years
• Progressive worsening over time
• Change in established headache pattern
• Headache triggered by exertion or positional change

When to Obtain Neuroimaging

Neuroimaging is not routinely indicated in patients with a typical history of tension-type headache and a normal neurological examination.

However, imaging should be considered in the following situations:

• Presence of red flag features
• Abnormal neurological examination
• New-onset headache in patients over 50 years of age
• Significant change in headache pattern
• Headache associated with exertion, posture, or Valsalva manoeuvre

In clinical practice, careful history-taking and examination remain the most important tools in distinguishing primary headache disorders from potentially serious secondary causes.

Pathophysiology of Tension-Type Headache

Tension-type headache is best understood as a disorder involving both peripheral and central mechanisms, with the relative contribution of each varying depending on the stage and chronicity of the condition. This evolving understanding has important implications for both diagnosis and treatment.

Peripheral Mechanisms

In episodic tension-type headache, pain arises primarily from myofascial structures in the head, neck, and shoulder regions. Myofascial trigger points, increased muscle tenderness, and sustained muscle contraction generate nociceptive input from pericranial tissues.

These peripheral drivers are often influenced by factors such as posture, repetitive strain, and stress-related muscle activation. Increased pericranial tenderness on examination reflects this peripheral nociceptive input and remains one of the most consistent clinical findings in tension-type headache.

This explains why treatments targeting peripheral mechanisms — including simple analgesics, physical therapy, and trigger point interventions — are often effective in episodic forms of the condition.

Central Sensitisation

In chronic tension-type headache, repeated and sustained peripheral nociceptive input leads to changes within the central nervous system, a process known as central sensitisation.

These changes include:

• Increased excitability of nociceptive neurons within the spinal dorsal horn and trigeminal nucleus
• Reduced descending inhibitory control from higher centres
• Development of widespread pain sensitivity beyond the original site of nociception

As a result, pain becomes amplified and less dependent on ongoing peripheral triggers. Patients may continue to experience persistent symptoms even when the original myofascial drivers are less prominent.

Peripheral–Central Continuum

The transition from episodic to chronic tension-type headache reflects a shift from predominantly peripheral mechanisms to central sensitisation. This is not an abrupt change but a gradual continuum in which both processes may coexist.

This concept has important clinical implications. Early and effective management of peripheral pain generators may reduce the risk of progression to chronic headache, while established chronic tension-type headache requires treatments that specifically target central pain processing.

Understanding this continuum is essential for selecting appropriate, mechanism-based treatment strategies and avoiding ineffective or poorly targeted interventions.

How Pathophysiology Guides Treatment

The peripheral–central model of tension-type headache is clinically important because it helps explain why different treatments are more effective at different stages of the condition. Treatment should not be selected purely on the label of “tension headache”, but on whether the dominant driver appears to be peripheral myofascial input, emerging central sensitisation, or established chronic central pain amplification.

In infrequent episodic tension-type headache, treatment is usually focused on reducing peripheral nociceptive input. In frequent episodic headache, early central changes may begin to appear, so physical therapy, biofeedback, and behavioural strategies become increasingly important. In chronic tension-type headache, central sensitisation is often the dominant mechanism, and preventive medication such as amitriptyline, combined with behavioural approaches, becomes more relevant.

This mechanism-based framework highlights why early, structured treatment is important. Treating episodic tension-type headache effectively may reduce the ongoing peripheral nociceptive input that contributes to chronification, while established chronic tension-type headache usually requires a broader strategy that addresses central sensitisation, medication overuse risk, sleep, stress, and musculoskeletal contributors.

Evidence-Based Treatment of Tension-Type Headache

Acute Treatment

For episodic tension-type headache, simple analgesics remain the mainstay of acute treatment. These medications work by reducing peripheral nociceptive input arising from myofascial structures and are most effective when taken early during an attack.

The most effective options include:

• Ibuprofen 400 mg
• Paracetamol (acetaminophen) 1,000 mg

Randomised trials have shown that both ibuprofen and paracetamol significantly increase the likelihood of being pain-free at 2 hours compared to placebo, with ibuprofen demonstrating slightly greater efficacy in some analyses. Other NSAIDs such as diclofenac and naproxen are also effective options.

Combination analgesics containing caffeine may provide additional benefit through synergistic mechanisms, although their use should be balanced against the risk of medication overuse.

Preventive Treatment

Preventive treatment should be considered in patients with frequent episodic or chronic tension-type headache, particularly when headaches occur on more than 10–15 days per month or are associated with significant functional impairment.

Amitriptyline is the first-line preventive medication and has the strongest evidence base. It works by enhancing descending inhibitory pathways and modulating central pain processing.

Treatment is typically started at a low dose (10–25 mg at night) and gradually titrated. Clinical benefit may take several weeks to become evident, with continued improvement over time.

Alternative options include:

• Mirtazapine
• Venlafaxine

These may be considered in patients who do not tolerate or respond to amitriptyline.

Combined Therapy: The Strongest Approach

The most effective treatment strategy for chronic tension-type headache is a combined approach that integrates pharmacological and behavioural therapies. This is particularly important given the interaction between peripheral input, central sensitisation, and psychological factors.

Combined therapy addresses both the biological and behavioural drivers of headache, leading to more consistent and sustained improvements compared to single-modality treatment.

This highlights the importance of addressing both central pain processing and behavioural factors such as stress, sleep, and coping strategies when managing chronic tension-type headache.

Non-Pharmacological Therapies

Non-pharmacological therapies play an important role in the management of tension-type headache, particularly in patients with frequent episodic or chronic symptoms. These approaches are especially valuable because they address muscle tension, stress physiology, pain coping, posture, and central pain processing without increasing the risk of medication overuse headache.

Biofeedback

Biofeedback has one of the strongest evidence bases among non-pharmacological treatments for tension-type headache. It helps patients recognise and modify physiological processes such as muscle tension, autonomic arousal, and stress-related bodily responses that may contribute to headache frequency and persistence.

EMG biofeedback and relaxation training can produce substantial reductions in headache activity, with benefits that may be maintained over time. Biofeedback appears particularly useful when combined with relaxation training, as this combination targets both peripheral muscle activity and central stress-related pain amplification.

Cognitive Behavioural Therapy and Stress Management

Cognitive behavioural therapy (CBT) and structured stress management can be helpful in selected patients, particularly where stress, anxiety, poor sleep, or maladaptive coping strategies contribute to headache persistence. CBT does not imply that the headache is “psychological”; rather, it addresses the interaction between stress physiology, attention to pain, behavioural responses, and central pain processing.

CBT is most effective when used as part of a broader treatment plan, especially when combined with relaxation training, biofeedback, physical therapy, or preventive medication.

Physical Therapy and Manual Therapy

Physical therapy and manual therapy may provide meaningful benefit, particularly in patients with prominent neck stiffness, pericranial tenderness, postural strain, or myofascial trigger points. These treatments aim to reduce peripheral nociceptive input from the cervical and pericranial muscles.

Manual joint mobilisation combined with exercise appears particularly helpful for reducing headache frequency. Other physiotherapy approaches, including soft-tissue mobilisation, trigger point therapy, stretching, postural rehabilitation, and TENS combined with physiotherapy, may improve headache intensity, frequency, and duration in selected patients.

Acupuncture and Dry Needling

Acupuncture and dry needling may be considered in selected patients, particularly where myofascial trigger points are prominent. The evidence is more variable than for some other approaches, but several studies suggest potential improvements in headache frequency, pain intensity, and quality of life.

Dry needling targets myofascial trigger points without injectate and may reduce peripheral nociceptive input from muscles such as the temporalis, trapezius, and suboccipital region. It should be viewed as an adjunct rather than a stand-alone treatment.

Practical Differences Between Treatment Approaches

The key clinical point is that non-pharmacological therapies are not merely “add-ons”. In chronic tension-type headache, they may be central to long-term management because they reduce reliance on analgesics, target perpetuating factors, and support durable improvement in headache control and function.

Interventional Treatments for Tension-Type Headache

Interventional treatments are not first-line for tension-type headache but play an important role in carefully selected patients, particularly those with refractory symptoms, prominent pericranial muscle tenderness, or coexisting cervicogenic contributors. When used appropriately, these techniques can reduce peripheral nociceptive input and support a more targeted, mechanism-based treatment strategy.

Trigger Point Injections

Trigger point injections are one of the most relevant interventional treatments for tension-type headache, particularly in patients with significant myofascial involvement. Hyperirritable trigger points within pericranial and cervical muscles act as peripheral pain generators and contribute to ongoing nociceptive input.

Common target muscles include the temporalis, trapezius, suboccipital muscles, and sternocleidomastoid. Injection of local anaesthetic into these trigger points can reduce muscle tension, interrupt nociceptive signalling, and lead to meaningful reductions in headache frequency and intensity.

When performed under ultrasound guidance, multiple muscle groups can be treated accurately and safely in a single session, improving both effectiveness and procedural precision.

Greater Occipital Nerve (GON) Blocks

Greater occipital nerve blocks are widely used in the management of headache disorders. While high-quality evidence specifically for tension-type headache is limited, this does not mean the technique lacks clinical utility.

In practice, GON blocks may be beneficial in selected patients, particularly where there is:

• Prominent occipital pain or tenderness
• Features suggesting a cervicogenic contribution
• Mixed headache patterns with overlap between headache types
• Diagnostic uncertainty, where response to a block may help clarify the dominant pain generator

The mechanism is thought to involve modulation of the trigeminocervical complex, reducing nociceptive input from cervical structures and potentially dampening central sensitisation.

GON blocks are therefore best considered an adjunctive, targeted intervention rather than a primary treatment for pure tension-type headache.

Lesser Occipital and Third Occipital Nerve Blocks

Lesser occipital and third occipital nerve blocks extend treatment to patients with more lateral or upper cervical pain distributions. These techniques are particularly relevant when there is a suspected cervicogenic component contributing to headache symptoms.

The third occipital nerve, which supplies the C2–C3 facet joint, may be an important contributor in patients with upper cervical joint dysfunction. Blocking this nerve can provide both diagnostic and therapeutic benefit.

Cervical Medial Branch Blocks

Cervical medial branch blocks target the nerves supplying the cervical facet joints and are considered in patients with coexisting neck pain, reduced cervical mobility, or suspected facet joint involvement.

These blocks may help identify and treat cervicogenic contributions to headache and can be particularly useful in patients whose symptoms do not fit a pure tension-type headache pattern.

Clinical Perspective

Interventional treatments should be viewed within the broader context of mechanism-based care. They are most effective when used in conjunction with pharmacological treatment, physical therapy, and behavioural strategies rather than as stand-alone interventions.

The key is careful patient selection. When peripheral drivers such as myofascial trigger points or cervical structures are clearly identified, targeted interventional treatments can provide meaningful benefit and help reduce reliance on systemic medications.

Why Botox Does NOT Work for Tension-Type Headache

Why the Differential Response Between Migraine and Tension-Type Headache?

The difference in response between migraine and tension-type headache reflects fundamental differences in underlying pathophysiology.

In chronic migraine, pain is driven by:

• Activation of trigeminal nociceptive pathways
• Release of neuropeptides such as CGRP and substance P
• Neurogenic inflammation
• Peripheral and central sensitisation

Botox works in migraine by inhibiting neurotransmitter release, reducing neurogenic inflammation, and modulating peripheral sensitisation within trigeminal pathways.

In contrast, tension-type headache is characterised by:

• Predominantly myofascial (peripheral) pain generators in episodic forms
• Central sensitisation without significant neurogenic inflammation in chronic forms

Critically, tension-type headache lacks the neuropeptide-driven inflammatory processes that Botox targets. This explains why Botox is effective in chronic migraine but not in tension-type headache.

Clinical Implications

Botox should not be used for tension-type headache. Patients labelled as having chronic tension-type headache who respond to Botox often have underlying or misclassified chronic migraine. Accurate diagnosis is therefore essential before considering advanced treatments.

Pain Spa Expert Care: Dr Krishna

At Pain Spa, the management of tension-type headache is based on a precision, mechanism-driven approach. Rather than applying a one-size-fits-all strategy, careful assessment is used to identify the dominant contributors to each patient’s symptoms, whether these are peripheral myofascial drivers, cervical sources, or features of central sensitisation.

A detailed clinical evaluation is undertaken to:

• Differentiate tension-type headache from migraine and cervicogenic headache
• Identify peripheral versus central pain mechanisms
• Recognise contributing factors such as posture, muscle dysfunction, and stress physiology
• Avoid misclassification and unnecessary or ineffective treatments

This structured approach ensures that treatment is targeted, efficient, and clinically appropriate, rather than escalating through ineffective options.

Dr Krishna’s Expertise

Dr Krishna has extensive experience in the assessment and management of complex headache and chronic pain conditions, with particular expertise in:

• Comprehensive headache diagnosis and differentiation
• Identification of myofascial and cervicogenic pain generators
• Integration of pharmacological, behavioural, and interventional strategies
• Ultrasound-guided interventional pain procedures

Treatments Offered at Pain Spa

• ✔ Ultrasound-guided trigger point injections
• ✔ Greater occipital nerve blocks
• ✔ Lesser occipital nerve blocks
• ✔ Third occipital nerve blocks
• ✔ Cervical medial branch blocks
• ✔ Structured pharmacological management (including amitriptyline and alternatives)
• ✔ Integration with physiotherapy and rehabilitation programmes
• ✔ Referral pathways for CBT and biofeedback
• ✔ Patient education and long-term self-management strategies

Why Ultrasound Guidance Matters

At Pain Spa, interventional procedures are performed under real-time ultrasound guidance, allowing precise visualisation of muscles, nerves, and surrounding structures. This enables:

• Accurate targeting of pain generators
• Improved safety by avoiding critical structures
• More effective delivery of treatment
• Better overall clinical outcomes

This level of precision is particularly important in tension-type headache, where treatment success often depends on accurately identifying and addressing specific peripheral pain sources.

Key Clinical Takeaways

References and Evidence Base

• International Headache Society. The International Classification of Headache Disorders, 3rd Edition (ICHD-3). Cephalalgia, 2018.
• Jensen R, Stovner LJ. Epidemiology and comorbidity of headache. The Lancet Neurology, 2008.
• Stovner LJ et al. Global, regional, and national burden of headache disorders. The Lancet Neurology, Global Burden of Disease Study.
• Bendtsen L et al. EFNS guideline on the treatment of tension-type headache. European Journal of Neurology, 2010.
• Bendtsen L, Evers S, Linde M et al. European Academy of Neurology guideline on the treatment of tension-type headache. European Journal of Neurology, 2020.
• Ashina S, Bendtsen L, Ashina M. Pathophysiology of tension-type headache. Current Pain and Headache Reports, 2005.
• Olesen J. The role of nitric oxide (NO) in migraine, tension-type headache and cluster headache. Pharmacology & Therapeutics, 2008.
• Holroyd KA et al. Management of chronic tension-type headache with tricyclic antidepressant medication, stress management therapy, and their combination. JAMA, 2001.
• Diener HC et al. Medication-overuse headache: a worldwide problem. The Lancet Neurology, 2010.
• Dodick DW et al. OnabotulinumtoxinA for treatment of chronic migraine. Headache, 2010.